Burden of IPF in Canada Report

The Burden of Idiopathic Pulmonary Fibrosis in Canada

This report reveals major gaps and disparities in care for Canadians living with idiopathic pulmonary fibrosis (IPF). Developed in collaboration with CPFF and Hoffmann-La Roche Limited, with input and guidance from a committee of IPF experts, the report provides credible, evidence-based information on the prevalence, economic impact, diagnosis and treatment of IPF. It uncovers the issues facing patients, their caregivers, and the health care professionals who treat them. Importantly, the report provides workable solutions to substantially alleviate the considerable burdens associated with the condition.